Literature DB >> 16552616

Cortisol levels in patients with severe community-acquired pneumonia.

Jorge I F Salluh1, Juan C Verdeal, Gustavo W Mello, Leonardo V Araújo, Gloria A R Martins, Marcelo de Sousa Santino, Márcio Soares.   

Abstract

OBJECTIVES: To evaluate cortisol levels and prevalence of adrenal insufficiency in patients with severe community-acquired pneumonia (CAP). DESIGN AND
SETTING: Retrospective cohort study in a 24-bed medical-surgical intensive care unit (ICU). PATIENTS: Forty patients with severe CAP admitted to the ICU from March 2003 and May 2005. MEASUREMENTS AND
RESULTS: Random cortisol levels were measured up to 72 h after ICU admission. A threshold of 20 microg/dl was considered for the diagnosis of adrenal insufficiency. Median cortisol levels were 15.5 microg/dl (IQR 10.8-25.1), and 26 patients (65%) met the criteria for adrenal insufficiency. Other cutoff levels of cortisol were evaluated, and 30 patients (75%) had cortisol levels below 25 microg/dl and 19 (47.5%) had cortisol levels below 15 microg/dl. When only patients with septic shock (n=19) were evaluated, 12 (63%) had adrenal insufficiency.
CONCLUSIONS: Relative adrenal insufficiency occurs in a high proportion of patients with severe CAP. This finding highlights the importance of measuring cortisol levels and may help explain the potential benefits of hydrocortisone infusion in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16552616     DOI: 10.1007/s00134-005-0046-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis.

Authors:  Djillali Annane; Eric Bellissant; Pierre Edouard Bollaert; Josef Briegel; Didier Keh; Yizhak Kupfer
Journal:  BMJ       Date:  2004-08-02

3.  Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.

Authors:  Didier Keh; Thomas Boehnke; Steffen Weber-Cartens; Christina Schulz; Olaf Ahlers; Sven Bercker; Hans-Dieter Volk; Wolf-Dietrich Doecke; Konrad J Falke; Herwig Gerlach
Journal:  Am J Respir Crit Care Med       Date:  2002-11-08       Impact factor: 21.405

Review 4.  Septic shock.

Authors:  Djillali Annane; Eric Bellissant; Jean-Marc Cavaillon
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

5.  The hepatoadrenal syndrome: a common yet unrecognized clinical condition.

Authors:  Paul E Marik; Timothy Gayowski; Thomas E Starzl
Journal:  Crit Care Med       Date:  2005-06       Impact factor: 7.598

6.  Cortisol levels and corticosteroid administration fail to predict mortality in critical illness: the confounding effects of organ dysfunction and sex.

Authors:  Mohamed Y Rady; Daniel J Johnson; Bhavesh Patel; Joel Larson; Richard Helmers
Journal:  Arch Surg       Date:  2005-07

7.  Measurements of serum free cortisol in critically ill patients.

Authors:  Amir H Hamrahian; Tawakalitu S Oseni; Baha M Arafah
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

8.  APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.

Authors:  W A Knaus; J E Zimmerman; D P Wagner; E A Draper; D E Lawrence
Journal:  Crit Care Med       Date:  1981-08       Impact factor: 7.598

9.  Adrenal insufficiency during septic shock.

Authors:  Paul E Marik; Gary P Zaloga
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

10.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  10 in total

1.  Serum cytokines and critical illness-related corticosteroid insufficiency.

Authors:  Yong Soo Kwon; Gee Young Suh; Kyeongman Jeon; So Young Park; So Yeon Lim; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon
Journal:  Intensive Care Med       Date:  2010-07-28       Impact factor: 17.440

2.  Sophisticated biomarkers for community-acquired pneumonia severity asessment: gadgets or useful tools?

Authors:  François G Brivet; Frédéric M Jacobs; Dominique Prat; Bogdan D Grigoriu
Journal:  Intensive Care Med       Date:  2008-01-08       Impact factor: 17.440

3.  Basal serum cortisol levels are not predictive of response to corticotropin but have prognostic significance in patients with septic shock.

Authors:  Yong Soo Kwon; Gee Young Suh; Eun-Hae Kang; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

Review 4.  Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis.

Authors:  Jirui Bi; Jin Yang; Ying Wang; Cijiang Yao; Jing Mei; Ying Liu; Jiyu Cao; Youjin Lu
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

5.  Association between Glucocorticoids and Mortality in Patients with Severe Pneumonia: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.

Authors:  Qiufeng Tang; Qiongyan Chen; Yanqing Li; Zuanjin Wang
Journal:  Comput Math Methods Med       Date:  2022-08-08       Impact factor: 2.809

6.  Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis.

Authors:  Wei Nie; Yi Zhang; Jinwei Cheng; Qingyu Xiu
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

Review 7.  Biomarkers in community-acquired pneumonia: a state-of-the-art review.

Authors:  Renato Seligman; Luis Francisco Ramos-Lima; Vivian do Amaral Oliveira; Carina Sanvicente; Elyara F Pacheco; Karoline Dalla Rosa
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

8.  Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization.

Authors:  Katsunaka Mikami; Masaru Suzuki; Hiroshi Kitagawa; Masaki Kawakami; Nobuaki Hirota; Hiromichi Yamaguchi; Osamu Narumoto; Yoshiko Kichikawa; Makoto Kawai; Hiroyuki Tashimo; Hidenori Arai; Tadashi Horiuchi; Yoshio Sakamoto
Journal:  Lung       Date:  2007-08-21       Impact factor: 3.777

Review 9.  The role of corticosteroids in severe community-acquired pneumonia: a systematic review.

Authors:  Jorge I F Salluh; Pedro Póvoa; Márcio Soares; Hugo C Castro-Faria-Neto; Fernando A Bozza; Patrícia T Bozza
Journal:  Crit Care       Date:  2008-06-11       Impact factor: 9.097

10.  Corticosteroids for community-acquired pneumonia: time to act!

Authors:  Djillali Annane; G Umberto Meduri
Journal:  Crit Care       Date:  2008-07-14       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.